Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Methylphenidate and risk of serious cardiovascular events in adults.

Schelleman H, Bilker WB, Kimmel SE, Daniel GW, Newcomb C, Guevara JP, Cziraky MJ, Strom BL, Hennessy S.

Am J Psychiatry. 2012 Feb;169(2):178-85. doi: 10.1176/appi.ajp.2011.11010125.

PMID:
22318795
2.

Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.

Westover AN, Halm EA.

BMC Cardiovasc Disord. 2012 Jun 9;12:41. doi: 10.1186/1471-2261-12-41. Review.

3.

Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Antel J, Albayrak Ö, Heusch G, Banaschewski T, Hebebrand J.

Eur Arch Psychiatry Clin Neurosci. 2015 Apr;265(3):233-47. doi: 10.1007/s00406-014-0522-8. Epub 2014 Aug 23. Review.

PMID:
25149468
4.

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review.

Brauer R, Douglas I, Smeeth L.

Br J Clin Pharmacol. 2011 Dec;72(6):871-8. doi: 10.1111/j.1365-2125.2011.04043.x. Review.

Supplemental Content

Support Center